Skip to main content
Amishi Shah, MD, Oncology, Houston, TX

Amishi Yogesh Shah MD


Physician

Join to View Full Profile
  • 1515 Holcombe BlvdHouston, TX 77030

  • Phone+1 713-792-6161

Are you Dr. Shah?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Amishi Shah, MD is an oncologist in Houston, Texas. She is currently licensed to practice medicine in Texas, Alabama, and Alabama.

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 2010 - 2013
  • Baylor College of Medicine
    Baylor College of MedicineClass of 2010

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • AZ State Medical License
    AZ State Medical License 2023 - 2026
  • GA State Medical License
    GA State Medical License 2023 - 2026
  • OK State Medical License
    OK State Medical License 2023 - 2026
  • TX State Medical License
    TX State Medical License 2016 - 2026
  • AL State Medical License
    AL State Medical License 2023 - 2025
  • AL State Medical License
    AL State Medical License 2023 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology
  • Join now to see all

Publications & Presentations

PubMed

Authored Content

  • 'Cabozantinib for the Treatment of Patients with Metastatic Non-Clear CellNovember 2018

Press Mentions

  • MDACC 2018: Neoadjuvant Strategies for Upper Tract Urothelial Carcinoma
    MDACC 2018: Neoadjuvant Strategies for Upper Tract Urothelial CarcinomaNovember 11th, 2018